Regency Silver Corp. (TSX-V:RSMX, OTCQB:RSMXF) said it has completed its Phase 1 drill program for 2023 with mineralized breccia intersected in 8 of 9 holes.
The company said the eight follow-up holes surrounding hole REG-22-01 have intersected sulphide-specularite supported breccias similar in nature to the breccia hosting gold-copper-silver mineralization in holes REG-22-01, REG-23-14 and REG-23-15.
Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) said it has launched its contactless integrative AI solutions for healthcare, which is aiming to revolutionize the industry in India.
The company's solution leverages advanced AI algorithms and state-of-the-art technology to enhance the efficiency, accuracy, and safety of healthcare practices across the country.
Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) told investors it is “extremely encouraged” by the progress of its Phase I/II study of Bexmarilimab, which is highlighted as showing continued efficacy signals.
The company, in a stock market statement, today said that three of five patients in the study (in one of the dosing cohorts: the 6 mg/kg bexmarilimab + azacitidine doublet) had objective responses.
Novo Resources Corp (TSX:NVO, OTCQX:NSRPF) is advancing its Australian exploration efforts in the second half of the year with an 8,000-metre drilling plan that targets key prospects in Western Australia's Pilbara region and at the Belltopper Gold Project in Victoria.
The surge in activity follows the A$10 million cornerstone investment the company secured alongside an earn-in and joint venture with De Grey Mining Ltd.
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) is celebrating today after an independent body verified positive Phase 1 clinical data for its lead RECCE® 327 (R327) drug candidate.
The healthcare stock is developing a new class of synthetic anti-infectives and recently conducted a randomised, placebo-controlled, first-in-human trial to evaluate how R327 performed as an intravenous infusion formulation in 80 healthy male subjects.
Imugene Ltd (ASX:IMU, OTC:IUGNF) welcomes the US Patent and Trademark Office’s (USPTO) granting of a crucial Notice of Allowance protecting the company’s oncolytic virotherapy CF33 patent until 2037.
The Notice of Allowance is for the clinical stage immuno-oncology company’s patent application number 16/324,541 titled 'Chimeric Poxvirus Composition and Uses Thereof', for CF33, including VAXINIA (CF33-hNIS) and CHECKVacc (CF33-hNIS-antiPDL1).
Toubani Resources Inc (ASX:TRE, OTC:AGGFF) has completed a successful regional drilling campaign, encountering gold at all seven drill-tested targets and expanding the mineralised strike at the Kobada Gold deposit in Mali to 11 kilometres from five kilometres.
The company struck gold at the Gosso, Kobada East, Kobada North 1 and 2, Kobada West, Kobada South and Junction/Foroko targets, with best results including 1-metre at 24.8 g/t gold and 9 metres at 1.72 g/t gold.
Imugene Ltd (ASX:IMU, OTC:IUGNF) has appointed two-decade veteran Dr Ron Weitzman as its interim chief medical officer, replacing Dr Giovanni Selvaggi.
Dr Weitzman brings extensive global experience to the company, along with his expertise in the therapeutic areas of solid tumour and hematologic malignancies.
Kainantu Resources Ltd said has closed around $300,000 second tranche of its private placement financing of $1.8 million, originally announced on May 30, 2023. Under the second tranche of the offering, the company has issued an aggregate of 3,710,449 senior convertible debentures at a price of eight cents per debenture to raise gross proceeds of $296,835.94. In the first tranche of the offering, the company issued an aggregate of 6,289,551 senior convertible debentures at a price of eight cents per debenture to raise gross proceeds of $503,164.06, originally announced on June 22, 2023. A final tranche of the offering of up to an additional $1 million remains open and is expected to close on or before August 11, 2023, with further updates provided in due course. The net proceeds from the offering are intended to be used, but are not limited to, the potential completion of the acquisition of the Kili Teke project.
Tajiri Resources Corp said it has closed the first tranche of its previously announced a non-brokered private placement. The company issued 3.91 million shares at a price of 3.5 cents per shares for proceeds to the company of $136,850.00. Insider participation totalled 1.6 million shares via a related party transaction. Proceeds from the offering will be used for ongoing project payments and general working capital. Final closing and acceptance of the offering is subject to the final approval of TSX Venture Exchange.
Graphene Manufacturing Group Ltd said has granted an aggregate of 227,277 restricted share units (RSUs) to certain officers of the company. The RSUs vest equally over 24 months. In addition, the company provided disclosure of previously granted RSUs for which public disclosure was not made. On October 12, 2022, the company granted an aggregate of 36,186 RSUs to certain directors of the company. On October 21, 2022, the company granted 20,952 RSUs to a director of the company. When vested, each RSU entitles the holder thereof to receive one common share of the company upon exercise in accordance with the plan. Additionally, the company said it has entered into three agreements to increase its investor relations outreach.
Baselode Energy Corp has provided a video update of the diamond drilling program on the ACKIO high-grade uranium zone as part of the larger program for the Hook project via the following link: https://www.youtube.com/watch?v=lDAHUjlRD_4. The video discusses the results of the 2023 drill campaign, the proximity of the discovery holes (AK21-001 to AK21-004) to AK23-095, and how the alteration in AK22-028 could be a "near-miss" vectoring in on new mineralization. A total of 15 drill holes (AK23-081 to AK23-095) in 3,214 metres have been completed of a planned 10,000 metres diamond drilling program. An additional 2,500 metres is partitioned in three to five areas for reconnaissance exploration to discover the next uranium zone on Hook. The drill program is anticipated to be complete by October. The company remains fully-funded to complete the program.
Century Global Commodities Corporation successfully closed its rights offering, issuing 19,700,914 common shares at $0.02 per share, generating gross proceeds of $394,018.28. The offering was oversubscribed by 75%, with all rights being fully subscribed, resulting in a total of 118,205,485 issued and outstanding shares upon completion. Insiders of the company subscribed for a significant portion of the shares.
Jolt Health Inc said it has closed its previously announced private placement of July 10, 2023, after issuing a total of 6,984,266 units for gross proceeds of $100,125 at $0.0143 per unit. Each unit consists of one common share and one common share warrant. Each warrant entitles the holder to subscribe for one additional common share for two years from the date of closing for five cents subject to the corporation's option to accelerate the expiry date if the stock trades at 15 cents for 10 trading days. The company noted that one insider subscribed for an aggregate of 1,400,000 units and that it has relied on exemptions from the valuation and minority shareholder approval requirements in respect of the insider participation.